Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in UNITED STATES :
sales of $45.80 billion
of which 100%
was pharmaceutical products),
Bristol-Myers Squibb Company
of which 28%
was Prioritized Brands-Revlimid), and
Merck & Co. , Inc.
of which 90%
was Merck Pharmaceutical).
During the year ended December of 2020, sales at
Pfizer Inc. were $41.91 billion.
decrease of 19.0%
versus 2019, when the company's sales were $51.75 billion.